Director Rhea J. Posedel filed a Form 4 with the SEC on August 14, 2026, reporting the sale of 5,973 shares of Aehr Test Systems common stock on that same date.

Key Highlights

  • Shares sold: Rhea J. Posedel disposed of 5,973 shares of common stock on 08/14/2026 at a price of $140 per share.
  • Indirect ownership: Following the transaction, Posedel holds 381,989 shares indirectly through a trust.
  • Direct ownership: Posedel also holds 47,156 shares directly, which the filing notes includes shares subject to unvested restricted stock units.
  • Role: The reporting person is identified as a Director of Aehr Test Systems (NASDAQ:AEHR).
  • Transaction code: The disposal is coded "S," indicating an open-market sale, according to the filing.

Posedel Trust Account Reduces Position in Aehr Test Systems

According to the Form 4 filed on August 14, 2026, director Rhea J. Posedel sold 5,973 shares of Aehr Test Systems common stock at $140 per share. The shares were disposed of from a position held indirectly through a trust. Following the reported transaction, the filing states that Posedel's indirect beneficial ownership through the trust stands at 381,989 shares.

The filing also discloses a separate direct holding of 47,156 shares. A footnote in the filing states that "the amount reported includes shares subject to unvested restricted stock units." No derivative securities transactions were reported in Table II of the form.

The Form 4 was signed by Chris Siu as Attorney-in-Fact on August 14, 2026. No amendment date was listed, indicating this is an original filing. The filing does not indicate whether the transaction was made pursuant to a Rule 10b5-1 trading plan, as the corresponding checkbox on the form was not selected.

What Was Disclosed

Director Rhea J. Posedel of Aehr Test Systems reported the sale of 5,973 shares at $140 each on August 14, 2026, with 381,989 shares remaining held indirectly through a trust and 47,156 shares held directly, the latter inclusive of unvested restricted stock units.